Skip to content

What makes it unique? Rationale of CytoSorb

ESICM Lives 2019
New data on hemoadsorption with CytoSorb in critically ill patients
Chair: JL Vincent, Brüssel, Belgien & M Singer, London, UK

Improved outcome of patients in septic shock
C Ince, Rotterdam, Niederlande

Advantages of CytoSorb compared to other liver support systems
J Stange, Rostock, Deutschland

What makes it unique? Rationale of CytoSorb
J Kellum, Pittsburgh, USA

Drug removal and safety aspects – What do we currently know
Z Molnar, Szeged, Ungarn

Improved outcome of patients in septic shock
C Ince, Rotterdam, Niederlande

Advantages of CytoSorb compared to other liver support systems
Jan Stange, Rostock, Germany

Play Video

Share

|

What makes it unique? Rationale of CytoSorb

Play Video

Share

|

ESICM Lives 2019
New data on hemoadsorption with CytoSorb in critically ill patients
Chair: JL Vincent, Brüssel, Belgien & M Singer, London, UK

Improved outcome of patients in septic shock
C Ince, Rotterdam, Niederlande

Advantages of CytoSorb compared to other liver support systems
J Stange, Rostock, Deutschland

What makes it unique? Rationale of CytoSorb
J Kellum, Pittsburgh, USA

Drug removal and safety aspects – What do we currently know
Z Molnar, Szeged, Ungarn

Improved outcome of patients in septic shock
C Ince, Rotterdam, Niederlande

Advantages of CytoSorb compared to other liver support systems
Jan Stange, Rostock, Germany

More Videos

Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
Jan Stange y Advantages compared to other liver support systems | ESICM Lives 2019: Webcast | SPA
Jan Stange y Advantages compared to other liver support systems | ESICM Lives 2019: Webcast | SPA
Hemoadsorption with CytoSorb in critically ill patients – new data and clinical experiences
Hemoadsorption with CytoSorb in critically ill patients – new data and clinical experiences